Skip to main content
Log in

Hypertension after multisystem inflammatory syndrome in children (MIS-C)

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Multisystem inflammatory syndrome in children (MIS-C) is associated with SARS-CoV-2. Long-term consequences of MIS-C remain unknown. The objective was to describe the prevalence and clinical predictors of hypertension (HTN) and elevated blood pressure (BP) following MIS-C.

Methods

A retrospective study of children ≤ 18 years admitted to a tertiary center with MIS-C was performed. HTN and elevated BP were classified as per the 2017 American Academy of Pediatrics Clinical Practice Guidelines and indexed to the 95th percentile. Data included demographics, inpatient clinical measures, and echocardiograms over 1-year follow-up. Data were analyzed using Kruskal–Wallis, chi-square, and logistic regression.

Results

Among 63 children hospitalized with MIS-C (mean age 9.7 ± 4.2 years, 58.7% male, body mass index (BMI) z-score 0.59 ± 1.9), 14% had HTN, and 4% had elevated BP > 30 days post-hospitalization. Multivariate linear regression analysis showed that BMI z-score was significantly associated with higher mean systolic (β = 2.664, CI = 1.307–3.980, p < 0.001) and diastolic (β = 2.547, CI = 0.605–4.489, p = 0.012) BP index > 30 days post-hospitalization. Acute kidney injury (AKI) (23.8%) (OR = 2.977, CI = 1.778–4.987, p < 0.001), peak inpatient serum creatinine (OR = 2.524, CI = 1.344–4.740, p = 0.004), and maximum CRP (OR = 1.009, CI = 1.002–1.016, p = 0.014) were all associated with increased odds of post-hospitalization HTN. Left ventricular hypertrophy was present in 46% while hospitalized, compared to 10% at last follow-up. All had return of normal systolic function.

Conclusions

Post-hospitalization HTN and elevated BP may be associated with MIS-C. Children with greater BMI or AKI may be at greater risk for developing HTN after MIS-C. MIS-C follow-up requires careful BP monitoring and antihypertensive medication consideration.

Graphical abstract

A higher resolution version of the Graphical abstract is available as Supplementary information

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Available upon request.

References

  1. CDC (2021) HAN archive - 00432. In: Health Alert Network (HAN). https://emergency.cdc.gov/han/2020/han00432.asp. Accessed 3 Jul 2023

  2. Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, Barranco MA, Maxted AM, Rosenberg ES, Easton D, Udo T, Kumar J, Pulver W, Smith L, Hutton B, Blog D, Zucker H, New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team (2020) Multisystem inflammatory syndrome in children in New York state. N Engl J Med 383:347–358. https://doi.org/10.1056/NEJMoa2021756

    Article  CAS  PubMed  Google Scholar 

  3. Basalely A, Gurusinghe S, Schneider J, Shah SS, Siegel LB, Pollack G, Singer P, Castellanos-Reyes LJ, Fishbane S, Jhaveri KD, Mitchell E, Merchant K, Capone C, Gefen AM, Steinberg J, Sethna CB (2021) Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19. Kidney Int 100:138–145. https://doi.org/10.1016/j.kint.2021.02.026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Valverde I, Singh Y, Sanchez-de-Toledo J, Theocharis P, Chikermane A, Di Filippo S, Kucinska B, Mannarino S, Tamariz-Martel A, Gutierrez-Larraya F, Soda G, Vandekerckhove K, Gonzalez-Barlatay F, McMahon CJ, Marcora S, Napoleone CP, Duong P, Tuo G, Deri A et al (2021) Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation 143:21–32. https://doi.org/10.1161/CIRCULATIONAHA.120.050065

    Article  CAS  PubMed  Google Scholar 

  5. Parr SK, Siew ED (2016) Delayed consequences of acute kidney injury. Adv Chronic Kidney Dis 2:186–194. https://doi.org/10.1053/j.ackd.2016.01.014

    Article  Google Scholar 

  6. Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, de Ferranti SD, Fulton DR, Burns JC, Newburger JW (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5:e003289. https://doi.org/10.1161/JAHA.116.003289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385. https://doi.org/10.1161/01.cir.94.6.1379

    Article  CAS  PubMed  Google Scholar 

  8. Hsu CY, Hsu RK, Yang J, Ordonez JD, Zheng S, Go AS (2016) Elevated BP after AKI. J Am Soc Nephrol 27:914–923. https://doi.org/10.1681/ASN.2014111114

    Article  CAS  PubMed  Google Scholar 

  9. Flynn JT, Kaelber DC, Baker-Smith CM, Subcommittee on Screening and Management of High Blood Pressure in Children et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. https://doi.org/10.1542/peds.2018-1739

    Article  PubMed  Google Scholar 

  10. Kidney Disease Improving Global Outcomes (2012) Summary of Recommendation Statements. Kidney Int Suppl 2:8–12. https://doi.org/10.1038/kisup.2012.7

  11. Sluysmans T, Colan SD (2016) Structural measurements and adjustments for growth. In: Echocardiography in Pediatric and Congenital Heart Disease. John Wiley & Sons, Ltd, Oxford, UK, pp 61–72

  12. Colan SD (2012) Normal echocardiographic values for cardiovascular structure. In: Lai WW, Mertens LL, Geva T, Cohen MS. Echocardiography in Pediatric and Congenital Heart Disease: From Fetus to Adult. John Wiley & Sons

  13. Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714. https://doi.org/10.1016/j.echo.2009.03.003

    Article  PubMed  Google Scholar 

  14. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999. https://doi.org/10.1161/CIR.0000000000000484

    Article  PubMed  Google Scholar 

  15. Tadic M, Cuspidi C, Mancia G, Dell’Oro R, Grassi G (2020) COVID-19, hypertension and cardiovascular diseases: should we change the therapy? Pharmacol Res 158:104906. https://doi.org/10.1016/j.phrs.2020.104906

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Barekat M, Shahrbaf MA, Rahi K, Vosough M (2022) Hypertension in COVID-19, a risk factor for infection or a late consequence? Cell J 24:424–426. https://doi.org/10.22074/cellj.2022.8487

    Article  PubMed  PubMed Central  Google Scholar 

  17. Chen G, Li X, Gong Z, Xia H, Wang Y, Wang X, Huang Y, Barajas-Martinez H, Hu D (2021) Hypertension as a sequela in patients of SARS-CoV-2 infection. PLos One 16:e0250815. https://doi.org/10.1371/journal.pone.0250815

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Jackson SL, Zhang Z, Wiltz JL, Loustalot F, Ritchey MD, Goodman AB, Yang Q (2018) Hypertension among youths—United States, 2001–2016. Am J Transplant 18:2356–2360. https://doi.org/10.1111/ajt.15050

    Article  Google Scholar 

  19. Song P, Zhang Y, Yu J, Zha M, Zhu Y, Rahimi K, Rudan I (2019) Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr 173:1154–1163. https://doi.org/10.1001/jamapediatrics.2019.3310

    Article  PubMed  PubMed Central  Google Scholar 

  20. Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, Garcia-May PK, Mhatre M, Usman MA, Abd-Elsalam S, Etuk S, Simmons LE, Napolitano R, Deantoni S, Liu B, Prefumo F, Savasi V, do Vale MS, Baafi E, Zainab G, Nieto R, et al (2021) Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol 225:e281–e289. https://doi.org/10.1016/j.ajog.2021.05.014

    Article  CAS  Google Scholar 

  21. Parker ED, Sinaiko AR, Kharbanda EO, Margolis KL, Daley MF, Trower NK, Sherwood NE, Greenspan LC, Lo JC, Magid DJ, O’Connor PJ (2016) Change in weight status and development of hypertension. Pediatrics 137:e20151662. https://doi.org/10.1542/peds.2015-1662

    Article  PubMed  PubMed Central  Google Scholar 

  22. Whitworth JA (1992) Adrenocorticotrophin and steroid-induced hypertension in humans. Kidney Int (Suppl 37):S34-S37. https://www.ncbi.nlm.nih.gov/pubmed/1321309

  23. Everett B, Zajacova A (2015) Gender differences in hypertension and hypertension awareness among adults. Biodemography Soc Biol 61:1–17. https://doi.org/10.1080/19485565.2014.929488

    Article  PubMed  PubMed Central  Google Scholar 

  24. Theocharis R, Wong J, Pushparajah K, Mathur SK, Simpson JM, Pascall E, Cleary A, Stewart K, Adhvaryu K, Savis A, Kabir SR, Uy MP, Heard H, Peacock K, Miller O (2021) Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. Eur Heart J Cardiovasc Imaging 22:896–903. https://doi.org/10.1093/ehjci/jeaa212

    Article  PubMed  Google Scholar 

  25. Belhadjer Z, Meot M, Bajolle F, Khraiche D, Legendre A, Abakka S, Auriau J, Grimaud M, Oualha M, Beghetti M, Wacker J, Ovaert C, Hascoet S, Selegny M, Malekzadeh-Milani S, Maltret A, Bosser G, Giroux N, Bonnemains L et al (2020) Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation 142:429–436. https://doi.org/10.1161/CIRCULATIONAHA.120.048360

    Article  CAS  PubMed  Google Scholar 

  26. Kobayashi R, Dionne A, Ferraro A, Harrild D, Newburger J, VanderPluym C, Gauvreau K, Son MB, Lee P, Baker A, de Ferranti S, Friedman KG (2021) Detailed assessment of left ventricular function in multisystem inflammatory syndrome in children, using strain analysis. CJC Open 3:880–887. https://doi.org/10.1016/j.cjco.2021.02.012

    Article  PubMed  PubMed Central  Google Scholar 

  27. Rao G (2016) Diagnosis, epidemiology, and management of hypertension in children. Pediatrics 138. https://doi.org/10.1542/peds.2015-3616

  28. Yang L, Magnussen CG, Yang L, Bovet P, Xi B (2020) Elevated blood pressure in childhood or adolescence and cardiovascular outcomes in adulthood: a systematic review. Hypertension 75:948–955. https://doi.org/10.1161/HYPERTENSIONAHA.119.14168

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Dr. Sethna is supported by NIH/NIDDK R01DK131091.

Author information

Authors and Affiliations

Authors

Contributions

All authors conceptualized and designed the study and critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. Conceptualization: J.L. and C.S.; methodology: J.L. and C.S.; formal analysis: J.L., C.S., and M.S.; data curation: J.L., M.S., C.S., E.M., and C.C.; writing—original draft preparation: J.L.; writing—review and editing: J.L., M.S., C.S., E.M., and C.C; supervision: C.S.

Corresponding author

Correspondence to Christine B. Sethna.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Institutional Review Board of Northwell Health. Consent from a guardian/parent and assent from children ≥ 7 years were obtained for the prospective piece of this study.

Consent for publication

N/A.

Competing interests

Dr. Sethna was on an advisory board for Travere Therapeutics. All other authors have no conflicting interests to disclose.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Graphical abstract (PPTX 91 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lehman, J.R., Schuchman, M., Mitchell, E. et al. Hypertension after multisystem inflammatory syndrome in children (MIS-C). Pediatr Nephrol 38, 4083–4091 (2023). https://doi.org/10.1007/s00467-023-06061-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-023-06061-2

Keywords

Navigation